These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1705151)

  • 41. Responders and non-responders to bifemelane hydrochloride in Alzheimer-type and multi-infarct dementia.
    Shigeta M; Nishikawa Y; Shimizu M; Usui M; Hyoki K; Kawamuro Y
    Int Clin Psychopharmacol; 1993; 8(2):109-14. PubMed ID: 8345159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
    Wada H
    Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes.
    Schmage N; Bergener M
    Int Psychogeriatr; 1992; 4 Suppl 1():89-99. PubMed ID: 1504290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
    Bidzan M; Bidzan L
    Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ateroid in the clinical treatment of multi-infarct dementia.
    Passeri M; Cucinotta D
    Mod Probl Pharmacopsychiatry; 1989; 23():85-94. PubMed ID: 2469953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent.
    Sourander LB; Portin R; Mölsä P; Lahdes A; Rinne UK
    Psychopharmacology (Berl); 1987; 91(1):90-5. PubMed ID: 3103163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological treatment strategies in Alzheimer type dementia.
    Gottfries CG
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):1-5. PubMed ID: 2136210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Options for treatment for dementia patients.
    Walsh AC
    J Am Geriatr Soc; 1990 Jul; 38(7):829-30. PubMed ID: 2370404
    [No Abstract]   [Full Text] [Related]  

  • 49. Aspirin and MID. Notes of caution.
    Cebul RD
    J Am Geriatr Soc; 1989 Jun; 37(6):573-5. PubMed ID: 2715564
    [No Abstract]   [Full Text] [Related]  

  • 50. Anticoagulant therapy for dementia.
    Walsh AC
    J Am Geriatr Soc; 1994 Feb; 42(2):227-8. PubMed ID: 8126343
    [No Abstract]   [Full Text] [Related]  

  • 51. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
    Banerjee S; Hellier J; Dewey M; Romeo R; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Knapp M; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
    Lancet; 2011 Jul; 378(9789):403-11. PubMed ID: 21764118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study.
    Barak Y; Plopski I; Tadger S; Paleacu D
    Int Psychogeriatr; 2011 Nov; 23(9):1515-9. PubMed ID: 21492498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
    Wilcock GK; Ballard CG; Cooper JA; Loft H
    J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donepezil for the treatment of agitation in Alzheimer's disease.
    Howard RJ; Juszczak E; Ballard CG; Bentham P; Brown RG; Bullock R; Burns AS; Holmes C; Jacoby R; Johnson T; Knapp M; Lindesay J; O'Brien JT; Wilcock G; Katona C; Jones RW; DeCesare J; Rodger M;
    N Engl J Med; 2007 Oct; 357(14):1382-92. PubMed ID: 17914039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
    Porsteinsson AP; Drye LT; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG;
    JAMA; 2014 Feb; 311(7):682-91. PubMed ID: 24549548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treating Depression in Dementia Patients: A Risk or Remedy-A Narrative Review.
    Sultan S
    Geriatrics (Basel); 2024 May; 9(3):. PubMed ID: 38804321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Converged avenues: depression and Alzheimer's disease- shared pathophysiology and novel therapeutics.
    Bajaj S; Mahesh R
    Mol Biol Rep; 2024 Jan; 51(1):225. PubMed ID: 38281208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
    Zhang J; Zheng X; Zhao Z
    BMC Neurol; 2023 May; 23(1):210. PubMed ID: 37259037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.